RXRX - Nvidia-Backed Recursion Pharmaceuticals Stock Is Up On Q1 Earnings: Everything You Need To Know | Benzinga
Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares are rising in Thursday’s after-hours session following the company’s first-quarter financial results.
Q1 Earnings: Recursion reported first-quarter revenue of $13.491 million, which beat analyst estimates of $12.65 million, according to Benzinga Pro. The company reported a quarterly loss of 39 cents per share, which beat estimates for a loss of 42 cents per share.
Net cash used in operating activities was $102.3 million in the first quarter. The company ended the quarter with $296.3 million in cash and cash equivalents.
Recursion said it’s on track to read out multiple Phase 2 clinical trials in the coming quarters, beginning in the third quarter.
“We ...